{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:26:03Z","timestamp":1773876363804,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Optum Epidemiology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There are limited data on risk factors for serious outcomes and death from COVID-19 among patients representative of the U.S. population. The objective of this study was to determine risk factors for critical care, ventilation, and death among hospitalized patients with COVID-19.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a cohort study using data from Optum\u2019s longitudinal COVID-19 electronic health record database derived from a network of healthcare provider organizations across the US. The study included patients with confirmed COVID-19 (presence of ICD-10-CM code U07.1 and\/or positive SARS-CoV-2 test) between January 2020 and November 2020. Patient characteristics and clinical variables at start of hospitalization were evaluated for their association with subsequent serious outcomes (critical care, mechanical ventilation, and death) using odds ratios (OR) and 95% confidence intervals (CI) from logistic regression, adjusted for demographic variables.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 56,996 hospitalized COVID-19 patients (49.5% male and 72.4%\u2009\u2265\u200950\u00a0years), 11,967 received critical care, 9136 received mechanical ventilation, and 8526 died. The median duration of hospitalization was 6\u00a0days (IQR: 4, 11), and this was longer among patients that experienced an outcome: 11\u00a0days (IQR: 6, 19) for critical care, 15\u00a0days (IQR: 8, 24) for mechanical ventilation, and 10\u00a0days (IQR: 5, 17) for death. Dyspnea and hypoxemia were the most prevalent symptoms and both were associated with serious outcomes in adjusted models. Additionally, temperature, C-reactive protein, ferritin, lactate dehydrogenase, D-dimer, and oxygen saturation measured during hospitalization were predictors of serious outcomes as were several in-hospital diagnoses. The strongest associations were observed for acute respiratory failure (critical care: OR, 6.30; 95% CI, 5.99\u20136.63; ventilation: OR, 8.55; 95% CI, 8.02\u20139.11; death: OR, 3.36; 95% CI, 3.17\u20133.55) and sepsis (critical care: OR, 4.59; 95% CI, 4.39\u20134.81; ventilation: OR, 5.26; 95% CI, 5.00\u20135.53; death: OR, 4.14; 95% CI, 3.92\u20134.38). Treatment with angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers during hospitalization were inversely associated with death (OR, 0.57; 95% CI, 0.54\u20130.61).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We identified several clinical characteristics associated with receipt of critical care, mechanical ventilation, and death among COVID-19 patients. Future studies into the mechanisms that lead to severe COVID-19 disease are warranted.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07383-6","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T08:04:33Z","timestamp":1651219473000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Predictors of critical care, mechanical ventilation, and mortality among hospitalized patients with COVID-19 in an electronic health record database"],"prefix":"10.1186","volume":"22","author":[{"given":"Andrea K.","family":"Chomistek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caihua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Robin","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel P.","family":"Ogilvie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert V.","family":"Gately","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer N.","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Enger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy D.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence T.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"7383_CR1","unstructured":"WHO Coronavirus Disease (COVID-19) Dashboard. [cited 2021 December 15]; Available from: https:\/\/covid19.who.int\/."},{"issue":"10223","key":"7383_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u201313.","journal-title":"Lancet"},{"issue":"18","key":"7383_CR3","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708\u201320.","journal-title":"N Engl J Med"},{"issue":"20","key":"7383_CR4","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052\u20139.","journal-title":"JAMA"},{"issue":"11","key":"7383_CR5","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061\u20139.","journal-title":"JAMA"},{"issue":"2","key":"7383_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/jpm11020135","volume":"11","author":"D Traversi","year":"2021","unstructured":"Traversi D, et al. Precision medicine and public health: new challenges for effective and sustainable health. J Pers Med. 2021;11(2):135.","journal-title":"J Pers Med"},{"issue":"8","key":"7383_CR7","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamainternmed.2020.2033","volume":"180","author":"W Liang","year":"2020","unstructured":"Liang W, et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. 2020;180(8):1081\u20139.","journal-title":"JAMA Intern Med"},{"issue":"10229","key":"7383_CR8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"key":"7383_CR9","unstructured":"Berenguer J, et al. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect. 2020."},{"key":"7383_CR10","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1093\/cid\/ciaa1012","volume":"72","author":"L Kim","year":"2020","unstructured":"Kim L, et al. Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the U.S. coronavirus disease 2019 (COVID-19)-associated hospitalization surveillance network (COVID-NET). Clin Infect Dis. 2020;72:e206.","journal-title":"Clin Infect Dis"},{"key":"7383_CR11","unstructured":"COVID-19 Hospitalization and Death by Race\/Ethnicity. [cited 2020 November 17]; Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/covid-data\/investigations-discovery\/hospitalization-death-by-race-ethnicity.html."},{"key":"7383_CR12","unstructured":"Garibaldi BT et al. Patient trajectories among persons hospitalized for COVID-19: a cohort study. Ann Intern Med. 2020."},{"issue":"26","key":"7383_CR13","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMsa2011686","volume":"382","author":"EG Price-Haywood","year":"2020","unstructured":"Price-Haywood EG, et al. Hospitalization and mortality among black patients and white patients with Covid-19. N Engl J Med. 2020;382(26):2534\u201343.","journal-title":"N Engl J Med"},{"issue":"6","key":"7383_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.12270","volume":"3","author":"G Suleyman","year":"2020","unstructured":"Suleyman G, et al. Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan detroit. JAMA Netw Open. 2020;3(6): e2012270.","journal-title":"JAMA Netw Open"},{"key":"7383_CR15","unstructured":"The COVID-19 Sex-Disaggregated Data Tracker. [cited 2020 December 12]; Available from: https:\/\/globalhealth5050.org\/the-sex-gender-and-covid-19-project\/."},{"key":"7383_CR16","doi-asserted-by":"publisher","first-page":"E63","DOI":"10.5888\/pcd17.200247","volume":"17","author":"DM Griffith","year":"2020","unstructured":"Griffith DM, et al. Men and COVID-19: a biopsychosocial approach to understanding sex differences in mortality and recommendations for practice and policy interventions. Prev Chronic Dis. 2020;17:E63.","journal-title":"Prev Chronic Dis"},{"issue":"7","key":"7383_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236618","volume":"15","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, et al. Prediction model and risk scores of ICU admission and mortality in COVID-19. PLoS ONE. 2020;15(7): e0236618.","journal-title":"PLoS ONE"},{"key":"7383_CR18","unstructured":"Lopes R, o.b.o.t.B.C.I. Continuing versus suspending ACE inhibitors and ARBs: impact of adverse outcomes in hospitalized patients with COVID-19\u2014the BRACE CORONA Trial. in European Society of Cardiology 2020 Congress. 2020."},{"key":"7383_CR19","unstructured":"Panel C-TG. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. [cited 2021 December 15]; Available from: https:\/\/www.covid19treatmentguidelines.nih.gov\/."},{"issue":"9","key":"7383_CR20","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.ajem.2020.05.073","volume":"38","author":"BM Henry","year":"2020","unstructured":"Henry BM, et al. Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: a pooled analysis. Am J Emerg Med. 2020;38(9):1722\u20136.","journal-title":"Am J Emerg Med"},{"issue":"4","key":"7383_CR21","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844\u20137.","journal-title":"J Thromb Haemost"},{"issue":"10","key":"7383_CR22","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2665-9913(20)30275-7","volume":"2","author":"JJ Manson","year":"2020","unstructured":"Manson JJ, et al. COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study. Lancet Rheumatol. 2020;2(10):e594\u2013602.","journal-title":"Lancet Rheumatol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07383-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07383-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07383-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T08:05:38Z","timestamp":1651219538000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07383-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7383"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07383-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"assertion":[{"value":"5 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable because this study utilized a commercially available, de-identified database. No administrative permissions were required for this study as this database has been certified as de-identified by an independent statistical expert following Health Insurance Portability and Accountability Act statistical de-identification rules and managed according to Optum<sup>\u00ae<\/sup> customer data use agreements. As no study team members had access to patient identifiers linked to the data, review by an ethics committee or institutional review board was not required, nor was consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AKC, CL, MCD, CRC, RPO, RVG, JNS, CE, FTW, and JDS are employees of Optum receiving stock and\/or stock options in UnitedHealth Group. NDL was formerly an employee of Optum and is currently an employee of IQVIA.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"413"}}